ID   CD47_RAT                Reviewed;         303 AA.
AC   P97829; O35294;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-OCT-2024, entry version 143.
DE   RecName: Full=Leukocyte surface antigen CD47;
DE   AltName: Full=Integrin-associated protein;
DE            Short=IAP;
DE   AltName: CD_antigen=CD47;
DE   Flags: Precursor;
GN   Name=Cd47;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RC   STRAIN=Wistar; TISSUE=Kidney;
RX   PubMed=9119739; DOI=10.1111/j.1349-7006.1997.tb00356.x;
RA   Nishiyama Y., Tanaka T., Naitoh H., Mori C., Fukumoto M., Hiai H.,
RA   Toyokuni S.;
RT   "Overexpression of integrin-associated protein (CD47) in rat kidney treated
RT   with a renal carcinogen, ferric nitrilotriacetate.";
RL   Jpn. J. Cancer Res. 88:120-128(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY, AND
RP   INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9592107; DOI=10.1523/jneurosci.18-11-04305.1998;
RA   Huang A.-M., Wang H.L., Tang Y.P., Lee E.H.Y.;
RT   "Expression of integrin-associated protein gene associated with memory
RT   formation in rats.";
RL   J. Neurosci. 18:4305-4313(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=Brown Norway; TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 43-57; 63-93; 123-128 AND 158-164, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87 AND SER-89,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-80 AND ASN-109, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
CC   -!- FUNCTION: Adhesive protein that mediates cell-to-cell interactions.
CC       Acts as a receptor for thrombospondin THBS1 and as modulator of
CC       integrin signaling through the activation of heterotrimeric G proteins.
CC       Involved in signal transduction, cardiovascular homeostasis,
CC       inflammation, apoptosis, angiogenesis, cellular self-renewal, and
CC       immunoregulation. Plays a role in modulating pulmonary endothelin EDN1
CC       signaling (By similarity). Modulates nitrous oxide (NO) signaling, in
CC       response to THBS1, hence playing a role as a pressor agent, supporting
CC       blood pressure (By similarity). Plays an important role in memory
CC       formation and synaptic plasticity in the hippocampus (PubMed:9592107).
CC       Receptor for SIRPA, binding to which prevents maturation of immature
CC       dendritic cells and inhibits cytokine production by mature dendritic
CC       cells. Interaction with SIRPG mediates cell-cell adhesion, enhances
CC       superantigen-dependent T-cell-mediated proliferation and costimulates
CC       T-cell activation (By similarity). Positively modulates FAS-dependent
CC       apoptosis in T-cells, perhaps by enhancing FAS clustering (By
CC       similarity). Plays a role in suppressing angiogenesis and may be
CC       involved in metabolic dysregulation during normal aging (By
CC       similarity). In response to THBS1, negatively modulates wound healing.
CC       Inhibits stem cell self-renewal, in response to THBS1, probably by
CC       regulation of the stem cell transcription factors POU5F1/OCT4, SOX2,
CC       MYC/c-Myc and KLF4 (By similarity). May play a role in membrane
CC       transport and/or integrin dependent signal transduction (By
CC       similarity). May prevent premature elimination of red blood cells (By
CC       similarity). {ECO:0000250|UniProtKB:Q08722,
CC       ECO:0000250|UniProtKB:Q61735, ECO:0000269|PubMed:9592107}.
CC   -!- SUBUNIT: Monomer. Interacts with THBS1 (via the C-terminal domain).
CC       Interacts with SIRPA. Interacts with FAS/CD95; interaction may be
CC       enhanced by functional activation. Interacts with SIRPG, UBQLN1 and
CC       UBQLN2. May interact with fibrinogen. {ECO:0000250|UniProtKB:Q08722}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P97829-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P97829-2; Sequence=VSP_015794, VSP_015795;
CC   -!- TISSUE SPECIFICITY: Expressed in hippocampus.
CC       {ECO:0000269|PubMed:9592107}.
CC   -!- INDUCTION: By ferric nitrilotriacetate, NMDA and amphetamine.
CC       {ECO:0000269|PubMed:9119739, ECO:0000269|PubMed:9592107}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D87659; BAA13420.1; -; mRNA.
DR   EMBL; AF017437; AAB70273.1; -; mRNA.
DR   EMBL; BC085740; AAH85740.1; -; mRNA.
DR   RefSeq; NP_062068.1; NM_019195.2. [P97829-1]
DR   AlphaFoldDB; P97829; -.
DR   SMR; P97829; -.
DR   BioGRID; 248018; 2.
DR   IntAct; P97829; 1.
DR   MINT; P97829; -.
DR   STRING; 10116.ENSRNOP00000068714; -.
DR   GuidetoPHARMACOLOGY; 2943; -.
DR   GlyCosmos; P97829; 6 sites, 23 glycans.
DR   GlyGen; P97829; 6 sites, 24 N-linked glycans (3 sites).
DR   iPTMnet; P97829; -.
DR   PhosphoSitePlus; P97829; -.
DR   SwissPalm; P97829; -.
DR   PaxDb; 10116-ENSRNOP00000050938; -.
DR   GeneID; 29364; -.
DR   KEGG; rno:29364; -.
DR   UCSC; RGD:2308; rat. [P97829-1]
DR   AGR; RGD:2308; -.
DR   CTD; 961; -.
DR   RGD; 2308; Cd47.
DR   VEuPathDB; HostDB:ENSRNOG00000001964; -.
DR   eggNOG; ENOG502RYTQ; Eukaryota.
DR   InParanoid; P97829; -.
DR   OrthoDB; 4635767at2759; -.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-391160; Signal regulatory protein family interactions.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P97829; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001964; Expressed in pancreas and 19 other cell types or tissues.
DR   ExpressionAtlas; P97829; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; ISO:RGD.
DR   GO; GO:0086080; F:protein binding involved in heterotypic cell-cell adhesion; IPI:ARUK-UCL.
DR   GO; GO:0070053; F:thrombospondin receptor activity; ISO:RGD.
DR   GO; GO:1904669; P:ATP export; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IDA:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IMP:ARUK-UCL.
DR   GO; GO:0071349; P:cellular response to interleukin-12; ISO:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; IMP:ARUK-UCL.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0070487; P:monocyte aggregation; ISO:RGD.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; IMP:ARUK-UCL.
DR   GO; GO:0008228; P:opsonization; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:2000439; P:positive regulation of monocyte extravasation; IMP:ARUK-UCL.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IMP:RGD.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IMP:ARUK-UCL.
DR   GO; GO:0050870; P:positive regulation of T cell activation; ISO:RGD.
DR   GO; GO:0060368; P:regulation of Fc receptor mediated stimulatory signaling pathway; IMP:ARUK-UCL.
DR   GO; GO:0032653; P:regulation of interleukin-10 production; ISO:RGD.
DR   GO; GO:0032655; P:regulation of interleukin-12 production; ISO:RGD.
DR   GO; GO:0032675; P:regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0045428; P:regulation of nitric oxide biosynthetic process; ISO:RGD.
DR   GO; GO:1905806; P:regulation of synapse pruning; ISO:RGD.
DR   GO; GO:0032680; P:regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0032649; P:regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0009617; P:response to bacterium; ISO:RGD.
DR   CDD; cd16090; IgV_CD47; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR006704; CD47.
DR   InterPro; IPR013147; CD47-like_TM.
DR   InterPro; IPR013270; CD47_Vset.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR037805; IgV_CD47.
DR   PANTHER; PTHR10613; LEUKOCYTE SURFACE ANTIGEN CD47; 1.
DR   PANTHER; PTHR10613:SF0; LEUKOCYTE SURFACE ANTIGEN CD47; 1.
DR   Pfam; PF04549; CD47; 1.
DR   Pfam; PF08204; V-set_CD47; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Integrin; Membrane; Phosphoprotein;
KW   Pyrrolidone carboxylic acid; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..303
FT                   /note="Leukocyte surface antigen CD47"
FT                   /id="PRO_0000042209"
FT   TOPO_DOM        19..140
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        141..161
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        162..173
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        174..194
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        195..206
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        207..227
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        228..238
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        239..259
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        260..266
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        267..287
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        288..303
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          19..125
FT                   /note="Ig-like V-type"
FT   MOD_RES         19
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250|UniProtKB:Q08722, ECO:0000305"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        34
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        61
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        80
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        109
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        204
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..261
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        41..112
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         8..11
FT                   /note="LLLG -> R (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9592107"
FT                   /id="VSP_015794"
FT   VAR_SEQ         302..303
FT                   /note="NN -> KAVEEPLNAFKESKGMMNDE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9592107"
FT                   /id="VSP_015795"
FT   MOD_RES         P97829-2:311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   303 AA;  32995 MW;  E849397AB0DA8D65 CRC64;
     MWPLAAALLL GSCCCGSAQL LLSKVKSVEF TSCNDTVVIP CKVLNVEAQS TDEMFVKWKL
     NKSYIFIYDG NKNSTTREQN FTSAKISVSD LLKGIASLTM DTHEAVVGNY TCEVTELSRE
     GKTVIELKNR PVSWFSTNEK ILIVIFPILA ILLFWGKFGI LTLKYKSSHT NKRIILLLVA
     GLALTLIVVV GAILFIPGEK PVKNASGLGL IVISTGILIL LQYNVFMTAF GMTSFTIAIL
     ITQVLGYVLA VVGMCLCIMA CEPVHGPLLI SGLGIIALAE LLGLVYMKFV ASNQRTIQPP
     RNN
//
